STAT News

STAT+: Ultragenyx cuts staff after another study fails

Ultragenyx announced that it's laying off about 20% of its staff as it ends development of two rare disease drugs.

By STAT News

1 min read
STAT+: Ultragenyx cuts staff after another study fails
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights